Evolent Health Yönetim

Yönetim kriter kontrolleri 2/4

Evolent Health CEO'su Seth Blackley, Jan2011 tarihinde atandı, in görev süresi 13.83 yıldır. in toplam yıllık tazminatı $ 8.93M olup, şirket hissesi ve opsiyonları dahil olmak üzere 8.8% maaş ve 91.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.27% ine doğrudan sahiptir ve bu hisseler $ 7.65M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.7 yıl ve 4.4 yıldır.

Anahtar bilgiler

Seth Blackley

İcra Kurulu Başkanı

US$8.9m

Toplam tazminat

CEO maaş yüzdesi8.8%
CEO görev süresi13.8yrs
CEO sahipliği0.3%
Yönetim ortalama görev süresi3.7yrs
Yönetim Kurulu ortalama görev süresi4.4yrs

Son yönetim güncellemeleri

Recent updates

We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Nov 07
We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Sep 19
Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Evolent Health: Let The Bidding Begin

Aug 23

Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Jul 29
Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Jul 01
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)

May 22

These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

May 05
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Apr 08
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Dec 21
Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

Nov 30
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

A First Evaluation On Evolent Health

Oct 04

Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

Sep 29
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

Sep 01
There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Aug 04
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Jul 19

Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Jun 14
Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

May 30
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

May 02
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Apr 17
Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M

Feb 22

Is Evolent Health (NYSE:EVH) A Risky Investment?

Feb 19
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return

Feb 15

Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Feb 01
Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Jan 14
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Evolent spikes as Humana partnership expands

Jan 12

Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Dec 27
Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Evolent Health offered $23.5M class action securities settlement

Sep 19

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Sep 18
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Improving Financials, But There's More

Aug 31

CEO Tazminat Analizi

Seth Blackley'un ücretlendirmesi Evolent Health'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$104m

Jun 30 2024n/an/a

-US$106m

Mar 31 2024n/an/a

-US$141m

Dec 31 2023US$9mUS$783k

-US$142m

Sep 30 2023n/an/a

-US$112m

Jun 30 2023n/an/a

-US$77m

Mar 31 2023n/an/a

-US$40m

Dec 31 2022US$8mUS$683k

-US$19m

Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$19m

Mar 31 2022n/an/a

-US$24m

Dec 31 2021US$7mUS$600k

-US$30m

Sep 30 2021n/an/a

-US$45m

Jun 30 2021n/an/a

-US$68m

Mar 31 2021n/an/a

-US$261m

Dec 31 2020US$4mUS$438k

-US$328m

Sep 30 2020n/an/a

-US$515m

Jun 30 2020n/an/a

-US$504m

Mar 31 2020n/an/a

-US$334m

Dec 31 2019US$3mUS$400k

-US$304m

Sep 30 2019n/an/a

-US$121m

Jun 30 2019n/an/a

-US$107m

Mar 31 2019n/an/a

-US$86m

Dec 31 2018US$2mUS$400k

-US$53m

Sep 30 2018n/an/a

-US$49m

Jun 30 2018n/an/a

-US$49m

Mar 31 2018n/an/a

-US$56m

Dec 31 2017US$2mUS$400k

-US$61m

Tazminat ve Piyasa: Seth 'nin toplam tazminatı ($USD 8.93M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 6.60M ).

Tazminat ve Kazançlar: Seth şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Seth Blackley (45 yo)

13.8yrs

Görev süresi

US$8,931,188

Tazminat

Mr. Seth Barrie Blackley serves as Chief Executive Officer at Evolent Health, Inc. since October 1, 2020. He serves as President of True Health Indiana, Inc. (True Health Indiana). Mr. Blackley co-founded...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Seth Blackley
Co-Founder13.8yrsUS$8.93m0.27%
$ 7.7m
Dan McCarthy
President2.2yrsUS$5.76m0.16%
$ 4.6m
John Johnson
Chief Financial Officer5.3yrsUS$3.53m0.15%
$ 4.2m
Emily Rafferty
Chief Operating Officer1.3yrsUS$2.69m0.055%
$ 1.6m
Jonathan Weinberg
Chief Legal Officer10.8yrsUS$2.01m0.11%
$ 3.1m
Aammaad Shams
Chief Accounting Officer4.4yrsUS$634.88k0.020%
$ 562.1k
Mark Mannion
Senior Vice President of Corporate Financeless than a yearVeri yokVeri yok
Robert Cruz
Chief Technology Officerno dataVeri yokVeri yok
Jessica White
Chief Information Officerless than a yearVeri yokVeri yok
Seth Frank
Vice President of Investor Relations2.9yrsVeri yokVeri yok
John Tam
Chief Strategy Officer12.8yrsVeri yokVeri yok
Scott Pritchard
President of Performance Suiteno dataVeri yokVeri yok

3.7yrs

Ortalama Görev Süresi

40.5yo

Ortalama Yaş

Deneyimli Yönetim: EVH 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.7 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Seth Blackley
Co-Founder6.6yrsUS$8.93m0.27%
$ 7.7m
Peter Grua
Independent Director4.8yrsUS$260.25k0.037%
$ 1.0m
Richard Jelinek
Independent Director1.4yrsUS$245.50k0.0059%
$ 166.2k
Russell Glass
Independent Directorless than a yearVeri yok0.0053%
$ 148.9k
Cheryl Scott
Independent Chairperson of the Board & Lead Independent Director9yrsUS$347.75k0.038%
$ 1.1m
Diane Holder
Independent Director13.3yrsUS$265.25k0.048%
$ 1.4m
Mary Duffy
Independent Director7.2yrsUS$255.25k0.035%
$ 992.2k
Kim Keck
Independent Director3.8yrsUS$265.25k0.019%
$ 523.9k
Craig Barbarosh
Independent Director3.9yrsUS$257.50k0.019%
$ 547.9k
Toyin Ajayi
Independent Director1.3yrsUS$195.83k0%
$ 0

4.4yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: EVH 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.4 yıldır).